Authors: DeFeo-Jones, D Garsky, VM Wong, BK Feng, DM Bolyar, T Haskell, K Kiefer, DM Leander, K McAvoy, E Lumma, P Wai, J Senderak, ET Motzel, SL Keenan, K Van Zwieten, M Lin, JH Freidinger, R Huff, J Oliff, A Jones, RE

Citation: D. Defeo-jones et al., A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo, NAT MED, 6(11), 2000, pp. 1248-1252

Authors: Lagu, B Tian, D Jeon, Y Li, C Wetzel, JM Nagarathnam, D Shen, QR Forray, C Chang, RSL Broten, TP Ransom, RW Chan, TB O'Malley, SS Schorn, TW Rodrigues, AD Kassahun, K Pettibone, DJ Freidinger, R Gluchowski, C

Citation: B. Lagu et al., De novo design of a novel oxazolidinone analogue as a potent and selectivealpha(1A) adrenergic receptor antagonist with high oral bioavailability, J MED CHEM, 43(15), 2000, pp. 2775-2778

Authors: Chang, RSL Chen, TB O'Malley, SS Pettibone, DJ DiSalvo, J Francis, B Bock, MG Freidinger, R Nagarathnam, D Miao, SW Shen, QR Lagu, B Dhar, TGM Tyagarajan, S Marzabadi, MR Wong, WC Gluchowski, C Forray, C

Citation: Rsl. Chang et al., In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist, EUR J PHARM, 409(3), 2000, pp. 301-312